A new study describes the correction of a rat model for inherited diabetes insipidus by gene therapy in the central nervous system (pages 1402–1404).
Article PDF
References
Valtin, H. Hereditary diabetes insipidus in rats (Brattleboro strain). Am. J. Med. 42, 814–827 (1967).
Geddes, B.J., Harding, T.C., Lightman, S.L. & Uney, J.B. Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin. Nature Med. 3, 1402–1404 (1997).
Schmale, H. & Richter, D. Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats. Nature 308, 705–709 (1984).
Ivell, R., Burback, P.H. & Leeuwen, F.W. The molecular biology of the Brattleboro rat. Front. Neuroendocrinol. 4, 313–338 (1990).
Sharif, M. & Hanley, M.R. V2-vasopressin peptide receptors. Nature 357, 279–280 (1992).
Rutishauer, J. et al. A novel point mutation in the translation initiation codon of the pre-provasopressin-neurophysin-II gene. J. Endocrinel. Metab. 81, 192–198 (1996).
Peltekian, E. et al. Adenovirus-mediated gene transfer to the brain: methodological assessment. J. Neurosci. Meths 71, 77–84 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hanley, M. Rats go with the (urine) flow. Nat Med 3, 1320 (1997). https://doi.org/10.1038/nm1297-1320
Issue Date:
DOI: https://doi.org/10.1038/nm1297-1320